Amgen Inc. (NASDAQ:AMGN) has a 1 Year Target Estimate of $182.21. The stock traded with the volume of 2.94 Million in the last trading session. Amgen Inc. opened at $145.36 and closed by showing an increase of 0.64%. The Bid price in the last session was $145.50 x 100 and the Ask price was $147.40 x 100. (The ask price is what sellers are willing to take for it. If you are selling a stock, you are going to get the bid price, if you are buying a stock you are going to get the ask price. The difference (or spread) goes to the broker/specialist that handles the transaction).
Amgen Inc. has the Market Capitalization of 108.61 Billion. The Stock has its 52-week High of $176.85 and 52-Week Low of $133.64 and it touched its 52-week high on Sep 23, 2016 and 52-Week Low on Nov 4, 2016.
Amgen Inc. reported its last Earnings on Oct 27 where the company reported Actual EPS of $3.02/Share whereas, the Analyst Estimated EPS was $2.79/share. The difference between Actual EPS and Estimated EPS was $0.23/share. This represented an Earnings Surprise of 8.2%. The company will report its next earnings on Jan 26 – Jan 30 (Est.).
Some analyst provided their insight on Growth Estimates; Amgen Inc. has the Current Quarter Earnings Growth rate of 7.3%. The Next Quarter growth is expected to be 1.7%. In the past 5 years, the stock has earnings growth rate of 17.15% per annum while the Upcoming 5 year’s earnings growth rate is expected to be 7.52% per annum.
19 number of analysts also provided their insight on Amgen Inc., where the Average Price Target for the stock is $182.21. They also projected Low Price Target as $157 while High Price Target is set at $209.
A number of analysts rated the stock as well: 2 analysts believe that the stock is a STRONG BUY while 11 reported it as Buy.11 analysts assigned a HOLD rating, 0 said it’s UNDERPERFORM and 0 say that this stock is a SELL.
Amgen Inc. annual Divided is 4 while it’s Dividend Yield is 2.74%. The stock has its Price to Earnings (P/E) ratio of 14.58 and Forward Price to Earnings ratio of 11.65. The company has its Price to Sales (P/S) ratio of 4.81 where Price to Book (P/B) ratio of 3.54, Price to Cash Per share (P/C) of 2.86 and Price to Free Cash Flow (P/FCF) has a value of 385.15.
The company has its Return on Assets (ROA) of 10.1 Percent. Return on Equity (ROE) stands at 25.8% and Return on Investment (ROI) displays a value of 12.5%.
The stock is currently trading at Distance from 20-Day simple moving Average of 1.91% whereas, Distance from 50-Day Simple moving average is -6.35 Percent and Distance from 200-Day Simple Moving Average of -6.46 percent.
A look at performance overview of Amgen Inc. depicts that Performance (Week) is 0.31 percent while Performance Month is 1.24%. Quarterly performance shows a value of -13.92% and Half Year Performance value stands at -6.46%. Yearly performance of the stock has the value of -6.98 percent. Amgen Inc. has its YTD performance of -7.69 Percent. (YTD performance is the most important factor to consider; if YTD is negative, the stock is declining; if the YTD Performance value is Positive the stock is surging).
Many Insiders have done trades inside the company. The latest trade was made on 31 Oct 2016 where Director Kullman (Ellen Jamison) did a transaction type “Buy” in which 355 shares were traded at a price of $0. Another insider trade includes Officer Patton Cynthia M who also initiated a transaction in which 1043 shares were traded on 25 Oct 2016 as “Sell”. On 24 Oct 2016 Officer Mcnamee Brian M traded 2109 shares as “Sell” at $158.76. Director de Carbonnel (François) Buy 5000 shares on 8 Sep 2016 at the price of $71.64.
The latest Upgrades/Downgrades was done by Research firm Mizuho on 8-Nov-16 who Initiated the stock to Buy. Other firms have also Upgraded/Downgraded the stock. On 26-Aug-16, Gabelli & Co took an action “Initiated” to Hold. On 29-Jun-16, the stock was Initiated to Mkt Perform by Bernstein.